WebJul 15, 2024 · Cynthia Chen, Pulnovo Medical's Chairwoman, said: "We are leveraging an accelerated regulatory pathway that is enabled by our FDA Breakthrough Device Designation. This first Pre-Sub meeting with the FDA allowed us to showcase our technological and clinical strengths and helped us gain insights into the IDE process for … WebSep 8, 2024 · Cynthia Chen, Pulnovo Medical's Chairwoman, said: "It was a great honor to have the support of a number of global experts in the cardiopulmonary field, all of whom showed great interest in participating in the PADN Global Clinical Trial.
How Chinese company Pulnovo Medical is curing pulmonary …
Web+855 1083806040 Pulnovo Medical Profile and History Founded in 2013, Pulnovo Medical is a wholly-owned Hong Kong enterprise that integrates development, production, and services. Our core products including the use pf radiofrequency ablation technology to treat pulmonary hypertension. WebAug 12, 2024 · Pulnovo Medical recently raised an undisclosed amount totaling millions of dollars in investment funding to support clinical trials and product development related to pulmonary arterial hypertension (PAH). “The road of global medical innovation has never been an easy journey,” Cynthia Chen, Pulnovo’s executive president, said in a press … dear gop stop investing in so much stuff
This week in PVD - pvrinstitute.org
WebDec 24, 2024 · Established in 2013 and rooted in innovation, Pulnovo Medical upholds evidenced-based research and translational medicine, and starts our research and development efforts alongside physicians at... WebNov 7, 2024 · Cynthia Chen, the Chief Strategy Officer in charge of Pulnovo's capital market and business development "Since the company completed the previous round of financing in August last year,... WebChaired by Cynthia Chen, the company’s core product is its PADN (Pulmonary Artery Denervation) device, which uses radiofrequency ablation to treat pulmonary arterial … generation hope therapy